Tigermed, a global CRO, opened its International Headquarters in Hong Kong, enabling Tigermed to coordinate and manage global projects more efficiently, drive business expansion. 
 
Tigermed established its Hong Kong office in 2011 and has partnered with local researchers and clinical sites for over a decade to advance innovative product development. The opening of Tigermed Headquarters in Hong Kong is part of the company’s commitment to expanding research capability and global reach to build a full-spectrum service platform.
 
With the support from Hong Kong Innovation, Technology, and Industry Bureau (ITIB), the Office for Attracting Strategic Enterprises (OASES), and various stakeholders across the industry, Tigermed International Headquarters is now ready to participate in the greater clinical development landscape in the region.  
 
Tigermed will collaborate with more global innovative enterprises and research institutions and provide high-quality CRO services for the pharmaceutical and medical device industries. With its extensive project experience and comprehensive technology platform, Tigermed aims to bring in global innovative projects to create a robust R&D system. 
 
“As a leading contract service provider, global development has always been a crucial part of our corporate strategy,” said Dr. Xiaoping Ye, Co-Founder and Chairman of Tigermed. “With the International Headquarters going into operation, we will continue strengthening the global presence and leveraging unique global layout to enhance service offerings and the connections with partners worldwide and serve as a bridge to advance healthcare breakthroughs for patients.”